aTyr Pharma

ATYR • NASDAQ • Stock Fundamentals

aTyr Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanjay S. Shukla, with a market cap of $47.5M.

Market Cap$47.5M

Employees59.0

CEOSanjay S. Shukla

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about aTyr Pharma

aTyr Pharma (ATYR) has a market capitalization of $47.5M and trades on NASDAQ.

aTyr Pharma has approximately 59 employees.